![](/img/cover-not-exists.png)
Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors.
Murray, J L, Cunningham, J E, Brewer, H, Mujoo, K, Zukiwski, A A, Podoloff, D A, Kasi, L P, Bhadkamkar, V, Fritsche, H A, Benjamin, R SVolume:
12
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.1994.12.1.184
Date:
January, 1994
File:
PDF, 852 KB
english, 1994